This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysis Of The U.S. Interventional Radiology And Cardiology X-ray Equipment Market

 

NEW YORK, May 8, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Analysis of the U.S. Interventional Radiology and Cardiology X-ray Equipment Market http://www.reportlinker.com/p01172015/Analysis-of-the-US-Interventional-Radiology-and-Cardiology-X-ray-Equipment-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory New Growth Opportunities Emerge in a Mature Market This research service pertains to the US market for interventional x-ray equipment used in radiology and cardiology. A thorough market sizing and forecasting model of market revenue, unit shipments, and pricing is included, along with analyses of technology trends, market drivers and restraints, and the competitive environment. The two market segments considered are interventional radiology (IR) and interventional cardiology (IC). The study also covers clinical specialties utilizing high-end interventional x-ray equipment, such as neurology and oncology. The base year of the study is 2012; the forecast period extends through 2019. Executive Summary

• Interventional x-ray equipment has been widely adopted by U.S. hospitals over the last 20 years, especially in the areas of radiology and cardiology. • The large installed base of equipment existing within a finite addressable market space creates a highly penetrated, mature, mainly replacement market. • This high degree of market maturity prevails mainly within the traditional interventional radiology (IR) and interventional cardiology (IC) markets. • The size of both the IR and IC segments has contracted during the last three years, owing to macroeconomic pressures coupled with a slowdown in replacement cycles. • While the revenue opportunity seems to have adjusted to a new lower level, the market outlook seemed to be reverting back to positive levels starting in the second half of 2012. This positive traction is due to the fact that both the IR and IC market segments also comprise smaller sub-segments that offer significant growth opportunities. • Such is the case of interventional oncology and interventional neurology, two sub-segments of IR that are poised to pursue their current growth dynamics. • Similarly, certain sub-segments of the IC market such as electrophysiology (EP) and other emerging minimally invasive procedures continue to exhibit robust growth. • Combined, these growth pockets hold the promise of offsetting some of the recent growth decays in the mature market segments, keeping the overall growth dynamics positive. • More so than the growth pockets driving, respectively, the IR and IC markets, it is the combined demand from these two segments that is creating the highest synergies. • As combo catheterization suites and hybrid operating rooms (OR) slowly emerge as a clinical best practice, they are driving demand for multipurpose interventional equipment. • The recovery of market growth is expected to be gradual, as installed base equipment lifecycles decay from the current X to X years toward seven to Xyears, as in the past. • This revival of replacement cycles will hinge on technology advances that pertain to the usability of equipment in these complex environments and combine multiple modalities. CEO's Perspective1. Replacement cycles are lengthening in mature segments, while emerging markets and procedures are offsetting part of the slowdown.2. Product and technology innovation cycles are lengthening due to mounting market and industry pressures.3. Technology advancement persists in advanced multimodality image guidance and visualization.4. Clinical guidelines continue to drive procedures toward noninvasive diagnostic and minimally invasive interventional techniques.5. Hybrid operating rooms and combination cath labs will emerge as clinical best practices, reviving market growth. Key Questions This Study Will Answer• Is the recent market slowdown and ensuing revenue decline a permanent one? Will the downward trend continue or give way to a more stable or increasing growth pattern?• Which growth segments of the market are most likely to accelerate the recovery of historic market size and growth rates, and over which period of time?• What are the key product technologies that have helped to revive legacy system replacement cycles and are likely to impact future market growth in the U.S. marketplace?• What are the main current and future developments in clinical guidelines expected to play a role either in favor or to the detriment of interventional x-ray equipment adoption?• What type of impact is the trend toward the development of hybrid operating rooms (OR) and combo cath labs expected to have on the evolution of the customer and market landscape?• What is the outlook on the current industry dynamics, and is the current concentration around the top three market participants likely to increase, or is the market more likely to diversify? Table Of Contents1. Executive Summary2. Market Overview3. Total Interventional Radiology and Cardiology X-ray Equipment Market• External Challenges: Drivers and Restraints• Forecast and Trends• Demand Analysis• Market Share and Competitive Analysis4. Interventional Radiology Segment Breakdown5. Interventional Cardiology Segment Breakdown6. The Last Word7. Appendix To order this report:: Analysis of the U.S. Interventional Radiology and Cardiology X-ray Equipment MarketContact Clare: clare@reportlinker.comUS:(339) 368 6001Intl:+1 339 368 6001

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,390.52 +195.10 1.13%
S&P 500 2,018.05 -2.75 -0.14%
NASDAQ 4,630.7410 +64.6030 1.41%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs